Document Detail


The role of MRI in the intestinal complications in cystic fibrosis.
MedLine Citation:
PMID:  11682294     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fibrosing colonopathy is a complication recently detected in children with cystic fibrosis (CF), and is thought to be associated with the use of high-strength pancreatic enzymes. The goal of this study was to evaluate the effectiveness of magnetic resonance (MR) in detecting possible pathologic gut findings in patients with CF under pancreatic enzyme treatment. Twenty-five patients with CF and pancreatic insufficiency, all under treatment with high-dose pancreatic enzymes, were studied by MR. MR was performed on a 1.5-T magnet by T1-weighted, 2D-FLASH fat-suppression, breath-hold sequences before and after intravenous administration of gadolinium, and by T2-weighted Turbo Spin-Echo (TSE) and Half-Fourier Acquisition Single-Shot Turbo Spin Echo (HASTE) fat-suppression, breath-hold sequences. A superparamagnetic negative oral contrast agent was given 1.5 h before the examination. MR showed a wall thickening of the terminal ileum and the ascending colon (>4-12 mm) in 22 patients; nine of them (wall thickness >4-6 mm) showed both a moderate hyperintensity of the bowel wall on T2-weighted sequences and an enhancement after intravenous gadolinium on T1-weighted sequences; 13 patients (wall thickness >6-12 mm) showed both a great wall enhancement after intravenous gadolinium and an increased signal intensity of the bowel wall on T2-weighted sequences. Fecal impaction without bowel wall involvement was detected in three patients. MR proved to be a useful, noninvasive, diagnostic tool for the evaluation of patients with CF and fibrosing colonopathy. The signal hyperintensity on T2-weighted sequences and the great wall enhancement after intravenous gadolinium administration indicating an acute edematous condition, provide the clinicians useful information for the therapeutic adjustment.
Authors:
M Almberger; E Iannicelli; M Antonelli; M Matrunola; G Cimino; R Passariello
Related Documents :
9722844 - Unselected brain 0.5-t mr imaging: comparison of lesion detection and characterization ...
9022774 - Mr appearance and spectral features of injected ethanol in the liver: implication for f...
2164234 - Pituitary microadenomas: diagnosis with two-and three-dimensional mr imaging at 1.5 t b...
8939244 - Skin: mr imaging findings at middle field strength.
1738994 - Mr imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for ...
9117914 - Is colour flow imaging needed to exclude clinically significant valvular regurgitation ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical imaging     Volume:  25     ISSN:  0899-7071     ISO Abbreviation:  Clin Imaging     Publication Date:    2001 Sep-Oct
Date Detail:
Created Date:  2001-10-29     Completed Date:  2001-12-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8911831     Medline TA:  Clin Imaging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  344-8     Citation Subset:  IM    
Affiliation:
Department of Radiology, University La Sapienza, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Child
Contrast Media
Cystic Fibrosis / complications*,  drug therapy
Enzymes / administration & dosage,  adverse effects
Exocrine Pancreatic Insufficiency / drug therapy,  etiology
Female
Gadolinium DTPA / diagnostic use
Humans
Intestinal Diseases / diagnosis*,  etiology
Magnetic Resonance Imaging / methods*
Male
Chemical
Reg. No./Substance:
0/Contrast Media; 0/Enzymes; 80529-93-7/Gadolinium DTPA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Omental infarction as a delayed complication of abdominal surgery.
Next Document:  Toxic megacolon: role of CT in evaluation and detection of complications.